UBS Group’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.93M | Buy |
133,074
+104,529
| +366% | +$1.21M | ﹤0.01% | 5007 |
|
|
2025
Q4 | $274K | Sell |
28,545
-238
| -0.8% | -$2.28K | ﹤0.01% | 6415 |
|
|
2025
Q3 | $271K | Sell |
28,783
-62,284
| -68% | -$595K | ﹤0.01% | 6492 |
|
|
2025
Q2 | $963K | Buy |
91,067
+77,015
| +548% | +$972K | ﹤0.01% | 5476 |
|
|
2025
Q1 | $211K | Sell |
14,052
-54,672
| -80% | -$910K | ﹤0.01% | 6525 |
|
|
2024
Q4 | $1.13M | Buy |
68,724
+61,184
| +811% | +$1.21M | ﹤0.01% | 5208 |
|
|
2024
Q3 | $186K | Buy |
7,540
+451
| +6% | +$11.7K | ﹤0.01% | 5930 |
|
|
2024
Q2 | $180K | Sell |
7,089
-11,640
| -62% | -$302K | ﹤0.01% | 5733 |
|
|
2024
Q1 | $476K | Buy |
18,729
+3,383
| +22% | +$81.9K | ﹤0.01% | 5245 |
|
|
2023
Q4 | $348K | Buy |
15,346
+5,970
| +64% | +$124K | ﹤0.01% | 5391 |
|
|
2023
Q3 | $175K | Sell |
9,376
-13,963
| -60% | -$290K | ﹤0.01% | 5447 |
|
|
2023
Q2 | $606K | Buy |
23,339
+3,393
| +17% | +$90.8K | ﹤0.01% | 4667 |
|
|
2023
Q1 | $573K | Sell |
19,946
-4,964
| -20% | -$148K | ﹤0.01% | 4585 |
|
|
2022
Q4 | $737K | Buy |
24,910
+19,129
| +331% | +$544K | ﹤0.01% | 4349 |
|
|
2022
Q3 | $137K | Buy |
5,781
+825
| +17% | +$19K | ﹤0.01% | 5428 |
|
|
2022
Q2 | $110K | Sell |
4,956
-24,207
| -83% | -$540K | ﹤0.01% | 5356 |
|
|
2022
Q1 | $732K | Sell |
29,163
-613
| -2% | -$18.7K | ﹤0.01% | 4398 |
|
|
2021
Q4 | $1.07M | Buy |
29,776
+9,339
| +46% | +$374K | ﹤0.01% | 4333 |
|
|
2021
Q3 | $870K | Buy |
20,437
+10,322
| +102% | +$425K | ﹤0.01% | 4303 |
|
|
2021
Q2 | $438K | Sell |
10,115
-9,450
| -48% | -$402K | ﹤0.01% | 4831 |
|
|
2021
Q1 | $798K | Buy |
19,565
+18,579
| +1,884% | +$705K | ﹤0.01% | 4472 |
|
|
2020
Q4 | $45K | Sell |
986
-1,127
| -53% | -$42.8K | ﹤0.01% | 6276 |
|
|
2020
Q3 | $75K | Buy |
2,113
+938
| +80% | +$33.9K | ﹤0.01% | 5356 |
|
|
2020
Q2 | $44K | Sell |
1,175
-5,741
| -83% | -$189K | ﹤0.01% | 5953 |
|
|
2020
Q1 | $200K | Buy |
6,916
+3,156
| +84% | +$128K | ﹤0.01% | 4725 |
|
|
2019
Q4 | $195K | Sell |
3,760
-33,524
| -90% | -$1.95M | ﹤0.01% | 5615 |
|
|
2019
Q3 | $2.05M | Buy |
37,284
+18,909
| +103% | +$971K | ﹤0.01% | 3270 |
|
|
2019
Q2 | $747K | Sell |
18,375
-90,757
| -83% | -$3.31M | ﹤0.01% | 3973 |
|
|
2019
Q1 | $3.3M | Buy |
109,132
+37,662
| +53% | +$1.29M | ﹤0.01% | 2552 |
|
|
2018
Q4 | $2.4M | Buy |
71,470
+8,616
| +14% | +$311K | ﹤0.01% | 2856 |
|
|
2018
Q3 | $2.65M | Buy |
62,854
+10,735
| +21% | +$424K | ﹤0.01% | 2955 |
|
|
2018
Q2 | $1.67M | Buy |
52,119
+49,026
| +1,585% | +$2.02M | ﹤0.01% | 3324 |
|
|
2018
Q1 | $154K | Sell |
3,093
-1,660
| -35% | -$93.8K | ﹤0.01% | 4945 |
|
|
2017
Q4 | $256K | Buy |
4,753
+2,189
| +85% | +$121K | ﹤0.01% | 4751 |
|
|
2017
Q3 | $148K | Buy |
2,564
+757
| +42% | +$39.6K | ﹤0.01% | 5053 |
|
|
2017
Q2 | $89K | Buy |
1,807
+86
| +5% | +$3.96K | ﹤0.01% | 5239 |
|
|
2017
Q1 | $75K | Sell |
1,721
-1,238
| -42% | -$59.1K | ﹤0.01% | 5238 |
|
|
2016
Q4 | $145K | Sell |
2,959
-12
| -0.4% | -$555 | ﹤0.01% | 5014 |
|
|
2016
Q3 | $142K | Buy |
2,971
+922
| +45% | +$45.5K | ﹤0.01% | 4771 |
|
|
2016
Q2 | $109K | Sell |
2,049
-14,587
| -88% | -$687K | ﹤0.01% | 4969 |
|
|
2016
Q1 | $744K | Buy |
16,636
+14,967
| +897% | +$607K | ﹤0.01% | 3484 |
|
|
2015
Q4 | $63K | Sell |
1,669
-875
| -34% | -$33.5K | ﹤0.01% | 5611 |
|
|
2015
Q3 | $82K | Buy |
2,544
+415
| +19% | +$14.5K | ﹤0.01% | 5386 |
|
|
2015
Q2 | $70K | Sell |
2,129
-12,680
| -86% | -$452K | ﹤0.01% | 5695 |
|
|
2015
Q1 | $609K | Sell |
14,809
-9,352
| -39% | -$378K | ﹤0.01% | 3972 |
|
|
2014
Q4 | $984K | Buy |
+24,161
| New | +$944K | ﹤0.01% | 3576 |
|
Other funds holding ANIK
CP
VCM
BFM
CM
